Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
November 15 2017 - 4:01PM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that Scott Drees, Chief Executive
Officer, and Walter Berger, Chief Operating Officer & Chief
Financial Officer, are scheduled to present at the 29th Annual
Piper Jaffray Healthcare Conference.
|
Event: |
29th Annual
Piper Jaffray Healthcare Conference |
|
Date: |
Tuesday,
November 28, 2017 |
|
Time: |
4:30 p.m.
ET |
|
Location: |
Lotte NY
Palace Hotel, New York |
A webcast of the Company’s presentation will be available by
visiting the investor relations section of Nuvectra’s website at
www.nuvectramed.com. A webcast replay of the chat will be available
for 90 days.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic conditions. The
Algovita® Spinal Cord Stimulation (SCS) System is our first
commercial offering and is CE marked and FDA approved for the
treatment of chronic intractable pain of the trunk and/or limbs.
Our innovative technology platform also has capabilities under
development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, COO &
CFO (214) 474-3102
wberger@nuvectramed.com
Investor Contacts:The Ruth Group
Zack Kubow / Brian Johnston(646) 536-7020 /
7028
investors@nuvectramed.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2023 to Jun 2024